Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: In the first intervention group, patients will be treated with gabapentin, 100 mg, once a day. Intervention 2: In the second intervention group, patients will be treated with gabapenti
Treatment - Drugs
In the first intervention group, patients will be treated with gabapentin, 100 mg, once a day.
In the second intervention group, patients will be treated with gabapentin, 300 mg, once a day.
In the third group, patients will be given no drugs.
Sponsors
Physical medicine and rehabilitation researches center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with isolated carpal tunnel syndrome; Exclusion criteria: Patients with carpal tunnel syndrome in the setting of other neurological diseases; Patients who had thenar atrophy or were treated with steroid injection in last 3 months; With known contraindication to or prior use of any antiepileptic drugs; Creatinine clearance <30 mL/min; Elevated liver enzymes; Clinically significant hematologic, cardiovascular, renal, or hepatic disease; History of narcotic or alcohol abuse; Previous carpal tunnel syndrome surgery.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of clinical symptoms. Timepoint: Before starting the study and two months after the initiation of the study. Method of measurement: By using Boston carpal tunnel questionnaire.;Functional status. Timepoint: Before starting the study and two months after the initiation of the study. Method of measurement: By using Boston carpal tunnel questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Arash Babaie
Tabriz University of Medical Sciences
Outcome results
None listed